JP Stock MarketDetailed Quotes

4893 Noile-Immune Biotech

Watchlist
  • 165
  • -2-1.20%
20min DelayMarket Closed Nov 1 15:00 JST
7.14BMarket Cap-6055P/E (Static)

Noile-Immune Biotech Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
0
-68.07%2.59M
-49.37%316.82M
-50.23%2.67M
302.8M
3.24M
8.1M
521.24%625.78M
5.37M
3.55%100.73M
Cost of revenue
0
-81.39%195K
-68.11%2.26M
164K
258K
787K
1.05M
-69.09%7.08M
671.01%22.9M
Gross profit
0
-66.09%2.39M
-49.16%314.56M
2.51M
302.54M
2.46M
7.05M
694.91%618.71M
-17.47%77.83M
Operating expense
59.76%342.53M
23.52%341.68M
50.33%1.09B
-38.42%282.04M
316.9M
214.4M
276.61M
-14.23%725.05M
457.99M
20.97%845.34M
Selling and administrative expenses
11.32%113.69M
44.35%147.36M
13.58%443.25M
-65.90%131.35M
--107.69M
--102.13M
--102.08M
18.07%390.25M
--385.16M
15.68%330.52M
-General and administrative expense
11.32%113.69M
44.35%147.36M
13.58%443.25M
--131.35M
--107.69M
--102.13M
--102.08M
18.07%390.25M
----
15.68%330.52M
Research and development costs
103.82%228.84M
11.34%194.32M
93.16%646.71M
106.91%150.69M
--209.22M
--112.28M
--174.52M
-34.97%334.8M
--72.83M
24.64%514.83M
Operating profit
-61.61%-342.53M
-25.87%-339.28M
-629.13%-775.39M
39.19%-279.53M
-14.36M
-211.94M
-269.56M
86.14%-106.35M
-459.7M
-26.97%-767.51M
Net non-operating interest income (expenses)
49K
27.27%28K
-20.00%44K
0
22K
0
22K
-31.25%55K
0
-97.94%80K
Non-operating interest income
--49K
27.27%28K
-20.00%44K
--0
--22K
--0
--22K
-31.25%55K
--0
-97.94%80K
Net investment income
88.75%-160K
-139.04%-310K
-99.91%5K
-88.02%550K
83K
-1.42M
794K
5.48M
4.59M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
0
Less:Write off
----
----
----
----
----
----
----
----
----
--0
Other non-operating income (expenses)
-24.30%-352.25M
0
-2.02M
-125.19M
-225.05M
-1,025.32%-283.39M
-265.81M
-613.20%-25.18M
Income before tax
-1.21%-342.64M
31.23%-339.57M
-193.49%-1.13B
33.41%-278.98M
-16.27M
-338.55M
-493.79M
51.53%-384.2M
-418.94M
-25.62%-792.62M
Income tax
0.00%605K
0.16%609K
0.00%2.42M
0.00%599K
608K
605K
608K
0.00%2.42M
599K
-57.36%2.42M
Net income
-1.20%-343.24M
31.19%-340.18M
-192.28%-1.13B
33.36%-279.58M
-16.88M
-339.16M
-494.4M
51.37%-386.62M
-419.54M
-24.88%-795.04M
Net income continuous operations
-1.20%-343.24M
31.19%-340.18M
-192.28%-1.13B
33.36%-279.58M
---16.88M
---339.16M
---494.4M
51.37%-386.62M
---419.54M
-24.88%-795.04M
Noncontrolling interests
Net income attributable to the company
-1.20%-343.24M
31.19%-340.18M
-192.28%-1.13B
33.36%-279.58M
-16.88M
-339.16M
-494.4M
51.37%-386.62M
-419.54M
-24.88%-795.04M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-1.20%-343.24M
31.19%-340.18M
-192.28%-1.13B
33.36%-279.58M
-16.88M
-339.16M
-494.4M
51.37%-386.62M
-419.54M
-24.88%-795.04M
Gross dividend payment
Basic earnings per share
7.14%-7.93
37.07%-7.86
-176.06%-27.25
39.76%-6.44
0.22
-8.54
-12.49
48.95%-9.8709
-10.6899
-24.88%-19.3347
Diluted earnings per share
7.14%-7.93
37.07%-7.86
-176.06%-27.25
39.57%-6.4603
-0.39
-8.54
-12.49
48.95%-9.8709
-10.6899
-24.88%-19.3347
Dividend per share
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Total revenue 0-68.07%2.59M-49.37%316.82M-50.23%2.67M302.8M3.24M8.1M521.24%625.78M5.37M3.55%100.73M
Cost of revenue 0-81.39%195K-68.11%2.26M164K258K787K1.05M-69.09%7.08M671.01%22.9M
Gross profit 0-66.09%2.39M-49.16%314.56M2.51M302.54M2.46M7.05M694.91%618.71M-17.47%77.83M
Operating expense 59.76%342.53M23.52%341.68M50.33%1.09B-38.42%282.04M316.9M214.4M276.61M-14.23%725.05M457.99M20.97%845.34M
Selling and administrative expenses 11.32%113.69M44.35%147.36M13.58%443.25M-65.90%131.35M--107.69M--102.13M--102.08M18.07%390.25M--385.16M15.68%330.52M
-General and administrative expense 11.32%113.69M44.35%147.36M13.58%443.25M--131.35M--107.69M--102.13M--102.08M18.07%390.25M----15.68%330.52M
Research and development costs 103.82%228.84M11.34%194.32M93.16%646.71M106.91%150.69M--209.22M--112.28M--174.52M-34.97%334.8M--72.83M24.64%514.83M
Operating profit -61.61%-342.53M-25.87%-339.28M-629.13%-775.39M39.19%-279.53M-14.36M-211.94M-269.56M86.14%-106.35M-459.7M-26.97%-767.51M
Net non-operating interest income (expenses) 49K27.27%28K-20.00%44K022K022K-31.25%55K0-97.94%80K
Non-operating interest income --49K27.27%28K-20.00%44K--0--22K--0--22K-31.25%55K--0-97.94%80K
Net investment income 88.75%-160K-139.04%-310K-99.91%5K-88.02%550K83K-1.42M794K5.48M4.59M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges) 0
Less:Write off --------------------------------------0
Other non-operating income (expenses) -24.30%-352.25M0-2.02M-125.19M-225.05M-1,025.32%-283.39M-265.81M-613.20%-25.18M
Income before tax -1.21%-342.64M31.23%-339.57M-193.49%-1.13B33.41%-278.98M-16.27M-338.55M-493.79M51.53%-384.2M-418.94M-25.62%-792.62M
Income tax 0.00%605K0.16%609K0.00%2.42M0.00%599K608K605K608K0.00%2.42M599K-57.36%2.42M
Net income -1.20%-343.24M31.19%-340.18M-192.28%-1.13B33.36%-279.58M-16.88M-339.16M-494.4M51.37%-386.62M-419.54M-24.88%-795.04M
Net income continuous operations -1.20%-343.24M31.19%-340.18M-192.28%-1.13B33.36%-279.58M---16.88M---339.16M---494.4M51.37%-386.62M---419.54M-24.88%-795.04M
Noncontrolling interests
Net income attributable to the company -1.20%-343.24M31.19%-340.18M-192.28%-1.13B33.36%-279.58M-16.88M-339.16M-494.4M51.37%-386.62M-419.54M-24.88%-795.04M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -1.20%-343.24M31.19%-340.18M-192.28%-1.13B33.36%-279.58M-16.88M-339.16M-494.4M51.37%-386.62M-419.54M-24.88%-795.04M
Gross dividend payment
Basic earnings per share 7.14%-7.9337.07%-7.86-176.06%-27.2539.76%-6.440.22-8.54-12.4948.95%-9.8709-10.6899-24.88%-19.3347
Diluted earnings per share 7.14%-7.9337.07%-7.86-176.06%-27.2539.57%-6.4603-0.39-8.54-12.4948.95%-9.8709-10.6899-24.88%-19.3347
Dividend per share
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg

No Data